[{"orgOrder":0,"company":"Laboratorio Elea Phoenix","sponsor":"Drugs for Neglected Diseases","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"","productType":"Other Small Molecule","year":"2021","type":"Inapplicable","leadProduct":"Benznidazole","moa":"antiprotozoal substances (metronidazole type)","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"Laboratorio Elea Phoenix","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Oral Tablet","sponsorNew":"Laboratorio Elea Phoenix \/ Drugs for Neglected Diseases","highestDevelopmentStatusID":"10","companyTruncated":"Laboratorio Elea Phoenix \/ Drugs for Neglected Diseases"},{"orgOrder":0,"company":"Fiocruz","sponsor":"Nortec Quimica","pharmaFlowCategory":"D","therapeuticArea":"Infections and Infectious Diseases","country":"BRAZIL","productType":"Other Small Molecule","year":"2023","type":"Partnership","leadProduct":"Benznidazole","moa":"antiprotozoal substances (metronidazole type)","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"Fiocruz","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Oral Tablet","sponsorNew":"Fiocruz \/ Nortec Quimica","highestDevelopmentStatusID":"8","companyTruncated":"Fiocruz \/ Nortec Quimica"}]

Find Clinical Drug Pipeline Developments & Deals for Benznidazole

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          ChemOutsourcing
                          Not Confirmed
                          ChemOutsourcing
                          Not Confirmed

                          Details : The partnership aims to improve the production of the active pharmaceutical ingredient (API) of benznidazole, the only drug used in Brazil for the Chagas disease.

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Undisclosed

                          February 05, 2023

                          Lead Product(s) : Benznidazole

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase II

                          Sponsor : Nortec Quimica

                          Deal Size : Undisclosed

                          Deal Type : Partnership

                          blank

                          02

                          Laboratorio Elea Phoenix

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Laboratorio Elea Phoenix

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          May 21, 2021

                          Lead Product(s) : Benznidazole

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase III

                          Sponsor : Drugs for Neglected Diseases

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          ChemOutsourcing
                          Not Confirmed
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          July 18, 2019

                          Lead Product(s) : Benznidazole

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase III

                          Sponsor : Chemo Research

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Drugs for Neglected Diseases

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Drugs for Neglected Diseases

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          March 27, 2019

                          Lead Product(s) : Benznidazole

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase I

                          Sponsor : PhinC Development

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          Instituto Nacional de Parasitologia Dr. Mario Fatala Chaben

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Instituto Nacional de Parasitologia Dr. Mario Fatala Chaben

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Lead Product(s) : Benznidazole

                          Therapeutic Area : Infections and Infectious Diseases

                          Study Phase : Phase III

                          Sponsor : National Council of Scientific Research, Argentina | Pan American Health Organization | Becas Carrillo Oñativia, Ministerio de Salud, Argentina | Drugs for Neglected Diseases

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          March 11, 2015

                          Lead Product(s) : Benznidazole

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase III

                          Sponsor : National Council of Scientific Research, Argentina | Pan American Health Organization | Becas Carrillo Oñativia, Ministerio de Salud, Argentina | Drugs for Neglected Diseases

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          Barcelona Centre for International Health Research

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Barcelona Centre for International Health Research

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          December 24, 2012

                          Lead Product(s) : Benznidazole

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase IV

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank